论文部分内容阅读
目的 :了解我院肿瘤住院病人护肝类药物的应用情况 ,为合理用药提供依据。方法 :对我院 2 0 0 2年 10月至 2 0 0 3年10月护肝类药物按用药金额排序、约定日剂量 (DDD值 )排序等方法 ,进行统计分析。结果 :临床在选择使用护肝类药有趋向性 ,以疗效显著的还原型谷胱甘肽注射液为首选。结论 :我院对肿瘤患者使用护肝药基本合理。高、中、低档药品应用基本均衡。疗效显著且价格适中的药物成为临床首选。
Objective: To understand the application of hepatoprotective drugs in inpatients with cancer in our hospital to provide evidence for rational drug use. Methods: From October 2002 to October 2003 in our hospital, the drugs for liver protection were sorted according to the amount of medication, the scheduled daily dose (DDD value) sorting and other methods for statistical analysis. Results: The clinical choice of the use of liver drugs tend to have a significant effect of reduced glutathione injection is preferred. Conclusion: The use of hepatoprotective drugs for cancer patients in our hospital is basically reasonable. High, medium and low-grade drugs are basically balanced. Significant effect and affordable drugs become the clinical choice.